Tisentotx
2 known investors
Tisento Therapeutics is a biopharmaceutical company developing zagociguat, an investigational oral, once-daily brain-penetrant soluble guanylate cyclase (sGC) stimulator, as a treatment for MELAS, a mitochondrial disease affecting multiple organ systems. Its work targets patients living with MELAS and other severe diseases that lack effective treatment options.
Investors · 2
Frequently asked questions
- What does Tisentotx do?
- Tisento Therapeutics is a biopharmaceutical company developing zagociguat, an investigational oral, once-daily brain-penetrant soluble guanylate cyclase (sGC) stimulator, as a treatment for MELAS, a mitochondrial disease affecting multiple organ systems. Its work targets patients living with MELAS and other severe diseases that lack effective treatment options.
- Who are Tisentotx's investors?
- Tisentotx's investors include Sanofi Ventures, Venrock.